Fluticasone/salmeterol (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "Fluticasone/salmeterol" in English language version.

refsWebsite

Global rank English rank

68^th place

117^th place

4web.archive.org

1^st place

1^st place

4^th place

4^th place

399^th place

333^rd place

3,912^th place

2,496^th place

2^nd place

2^nd place

3,984^th place

2,622^nd place

447^th place

338^th place

low place

low place

918^th place

556^th place

clincalc.com

"The Top 300 of 2022". ClinCalc. Archived from the original on 30 August 2024. Retrieved 30 August 2024.
"Fluticasone; Salmeterol Drug Usage Statistics, United States, 2013 - 2022". ClinCalc. Retrieved 30 August 2024.

doi.org

Salpeter SR, Buckley NS, Ormiston TM, Salpeter EE (June 2006). "Meta-analysis: effect of long-acting beta-agonists on severe asthma exacerbations and asthma-related deaths". Ann. Intern. Med. 144 (12): 904–12. doi:10.7326/0003-4819-144-12-200606200-00126. PMID 16754916.
Muley P, Shah M, Muley A (July 2013). "Safety of inhaled fluticasone propionate therapy for pediatric asthma - a systematic review". Current Drug Safety. 8 (3): 186–194. doi:10.2174/15748863113089990038. PMID 23859431.

drugs.com

"Fluticasone and Salmeterol inhalation - FDA prescribing information, side effects and uses". Drugs.com. Retrieved 4 March 2019.
"Fluticasone / salmeterol Pregnancy and Breastfeeding Warnings". Drugs.com. Retrieved 3 March 2019.

europa.eu

ema.europa.eu

"Seffalair Spiromax: Pending EC decision". European Medicines Agency (EMA). 1 February 2021. Archived from the original on 10 February 2021. Retrieved 1 February 2021.
"BroPair Spiromax: Pending EC decision". European Medicines Agency (EMA). 1 February 2021. Archived from the original on 13 April 2021. Retrieved 1 February 2021.
"Seffalair Spiromax EPAR". European Medicines Agency (EMA). 25 January 2021. Retrieved 23 August 2021.
"BroPair Spiromax EPAR". European Medicines Agency (EMA). 25 January 2021. Retrieved 23 August 2021.

ec.europa.eu

"Seffalair Spiromax Product information". Union Register of medicinal products. Retrieved 3 March 2023.
"BroPair Spiromax Product information". Union Register of medicinal products. Retrieved 3 March 2023.

fda.gov

"FDA approves first generic Advair Diskus". U.S. Food and Drug Administration (FDA) (Press release). Retrieved 30 January 2019.

justice.gov

"GlaxoSmithKline to Plead Guilty and Pay $3 Billion to Resolve Fraud Allegations and Failure to Report Safety Data". Department of Justice: Office of Public Affairs. 2 July 2012.

nih.gov

dailymed.nlm.nih.gov

"Advair Diskus- fluticasone propionate and salmeterol powder". DailyMed. 30 June 2023. Retrieved 8 September 2024.
"Advair HFA- fluticasone propionate and salmeterol xinafoate aerosol, metered". DailyMed. 23 May 2024. Retrieved 8 September 2024.

pubmed.ncbi.nlm.nih.gov

Salpeter SR, Buckley NS, Ormiston TM, Salpeter EE (June 2006). "Meta-analysis: effect of long-acting beta-agonists on severe asthma exacerbations and asthma-related deaths". Ann. Intern. Med. 144 (12): 904–12. doi:10.7326/0003-4819-144-12-200606200-00126. PMID 16754916.
Muley P, Shah M, Muley A (July 2013). "Safety of inhaled fluticasone propionate therapy for pediatric asthma - a systematic review". Current Drug Safety. 8 (3): 186–194. doi:10.2174/15748863113089990038. PMID 23859431.

sign.ac.uk

"Guideline 101: British Guideline on the Management of Asthma". British Thoracic Society & Scottish Intercollegiate Guidelines Network (SIGN). Archived from the original on 18 April 2015.

tga.gov.au

"Seroflo Multihaler (Cipla Australia Pty Ltd)". Department of Health and Ages Care. Retrieved 1 April 2023.

web.archive.org

"The Top 300 of 2022". ClinCalc. Archived from the original on 30 August 2024. Retrieved 30 August 2024.
"Guideline 101: British Guideline on the Management of Asthma". British Thoracic Society & Scottish Intercollegiate Guidelines Network (SIGN). Archived from the original on 18 April 2015.
"Seffalair Spiromax: Pending EC decision". European Medicines Agency (EMA). 1 February 2021. Archived from the original on 10 February 2021. Retrieved 1 February 2021.
"BroPair Spiromax: Pending EC decision". European Medicines Agency (EMA). 1 February 2021. Archived from the original on 13 April 2021. Retrieved 1 February 2021.